Search Thermo Fisher Scientific
Search Thermo Fisher Scientific
In-depth cell therapy product characterization remains central to the successful development of safe and efficacious cell therapies. Regulatory agencies require release testing to confirm the identity, purity, potency and safety of cell-based products. Thermo Fisher Scientific now offers novel, robust and reproducible identity and purity assays for CD8+ cells, regulatory T cells (Treg) and T helper cells (Th17) that are ready to be implemented in cell therapy manufacturing.
The Applied Biosystems Cell Therapy Systems (CTS) PureQuant Assays provide an alternative to flow cytometry to accurately identify and quantify CD8+ T cells, Tregs and Th17 cells in a mixed population. These new TaqMan® qPCR-based assay kits measure genomic DNA methylation at specific sites that serve as a unique cell type specific identifier. Assays include all reagents, standards and controls.
Figure 1. CTS PureQuant Treg Assay compared to flow cytometry for highly purified Treg populations derived from three different donors.
The Invitrogen eBioscience Essential Phenotyping Kits are designed for flow cytometry–based identity testing of T cells, Tregs, and Th1/Th17 cells. These turnkey kits leverage high-quality eBioscience antibodies, isotype controls and reagents (when applicable) and include a ready-to-use protocol for experimental set up and analysis.
Cell & Gene Therapy Learning Center
This collection of resources will help you gain a better understanding of cell therapy research
Cell Therapy Brochure
Learn about our solutions to help you achieve your cell therapy goals from research to commercialization
CTS Brochure
Learn more about our Cell Therapy Systems product offerings with our CTS brochure
Selection guide
Get help choosing cell therapy products for your cell type
Need technical support?
Contact our experienced technical and regulatory support team for CTS products
Request more information
Learn about our solutions to help you achieve your cell therapy goals from research to commercialization